Cargando…

Advances in cancer treatment: a new therapeutic target, Annexin A2

Annexin A2 (ANXA2) is a calcium regulated phospholipid-binding protein. It is expressed in some tumor cells, endothelial cells, macrophages, and mononuclear cells, affecting cell survival and mediating interactions between intercellular and extracellular microenvironment. Aberrant expression of ANXA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zinan, Yu, Lifeng, Hu, Baohui, Chen, Lianze, Jv, Mingyi, Wang, Lin, Zhou, Chenyi, Wei, Minjie, Zhao, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120175/ https://www.ncbi.nlm.nih.gov/pubmed/33995636 http://dx.doi.org/10.7150/jca.55173

Ejemplares similares

Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanoma
por: Hu, Baohui, et al.
Publicado: (2020)

A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer
por: Ju, Mingyi, et al.
Publicado: (2021)

m(6)A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma
por: Chen, Lianze, et al.
Publicado: (2021)

Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity
por: Song, Xinyue, et al.
Publicado: (2021)

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
por: Gou, Rui, et al.
Publicado: (2019)

Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma
por: Chen, Chang-Yu, et al.
Publicado: (2015)

Screening of an annexin‐A2‐targeted heptapeptide for pancreatic adenocarcinoma localization
por: Ma, Heyao, et al.
Publicado: (2022)

Therapeutic potential for targeting Annexin A1 in fibrotic diseases
por: Yan, Zhibin, et al.
Publicado: (2022)

Advancements of Annexin A1 in inflammation and tumorigenesis
por: Shao, Gang, et al.
Publicado: (2019)

The Effect of Annexin A1 as a Potential New Therapeutic Target on Neuronal Damage by Activated Microglia
por: You, Ji-Eun, et al.
Publicado: (2021)

Annexin A2 and Kidney Diseases
por: Lin, Ling, et al.
Publicado: (2022)

AnnexinA6: a potential therapeutic target gene for extracellular matrix mineralization
por: Yang, Jie, et al.
Publicado: (2023)

Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer
por: Ju, Mingyi, et al.
Publicado: (2022)

LYPD3, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia
por: Hu, Tingting, et al.
Publicado: (2022)

Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma
por: Chen, Chang-Yu, et al.
Publicado: (2018)

Annexin-A1: Therapeutic Potential in Microvascular Disease
por: Purvis, Gareth S. D., et al.
Publicado: (2019)

Therapeutic Potential of Annexins in Sepsis and COVID-19
por: Mui, Louise, et al.
Publicado: (2021)

Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer
por: Wang, Lin, et al.
Publicado: (2021)

The annexins
por: Moss, Stephen E, et al.
Publicado: (2004)

Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target
por: Zeidan, Bashar, et al.
Publicado: (2015)

Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury
por: Ansari, Junaid, et al.
Publicado: (2018)

LncRNA SPRY4‐IT1 regulates breast cancer cell stemness through competitively binding miR‐6882‐3p with TCF7L2
por: Song, Xinyue, et al.
Publicado: (2019)

Annexin A5 stabilizes matrix vesicle-biomimetic lipid membranes: unravelling a new role of annexins in calcification
por: Ferreira, Claudio R., et al.
Publicado: (2023)

Identification and Validation of an Annexin-Related Prognostic Signature and Therapeutic Targets for Bladder Cancer: Integrative Analysis
por: Yao, Xitong, et al.
Publicado: (2022)

MicroRNA-425-5p modulates osteoporosis by targeting annexin A2
por: Chen, Guanghua, et al.
Publicado: (2021)

Therapeutic Potential of Annexin A1 Modulation in Kidney and Cardiovascular Disorders
por: Mozaffari, Mahmood S.
Publicado: (2021)

Annexins in Glaucoma
por: Yap, Timothy E., et al.
Publicado: (2018)

Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides
por: Nonaka, Motohiro, et al.
Publicado: (2021)

Comprehensive analyses of the annexin gene family in wheat
por: Xu, Lei, et al.
Publicado: (2016)

Bioinformatics Analysis of Bacterial Annexins – Putative Ancestral Relatives of Eukaryotic Annexins
por: Kodavali, Praveen Kumar, et al.
Publicado: (2014)

Annexin A3 and cancer
por: Liu, Chao, et al.
Publicado: (2021)

Advances in rheumatology: new targeted therapeutics
por: Tak, Paul P, et al.
Publicado: (2011)

Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer
por: Choi, Chel Hun, et al.
Publicado: (2016)

Annexin A1 in the nervous and ocular systems
por: Wang, Aijia, et al.
Publicado: (2023)

Integrin Targeting Enhances the Antimelanoma Effect of Annexin V in Mice
por: Zhu, Jingyi, et al.
Publicado: (2023)

Annexin A2 as a target endothelial cell membrane autoantigen in Behçet's disease
por: Chen, Peng, et al.
Publicado: (2015)

A new biomarker combining multimodal MRI radiomics and clinical indicators for differentiating inverted papilloma from nasal polyp invaded the olfactory nerve possibly
por: Du, Lianze, et al.
Publicado: (2023)

MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
por: Zhao, Lin, et al.
Publicado: (2016)

A panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysis
por: Lu, Chih-Ming, et al.
Publicado: (2014)

Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
por: Zhao, Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tkr4gscrcgee0ii6agedkddljo